Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Acute Pain After Rattlesnake Envenomation
NCT05379179Phase 4Terminated
- Start
- Jun 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ketamine in rattlesnake envenomation (2 arms). Primary endpoint: Change in Pain Assessment Post Medication. Started Jun 2022; status: terminated.
02
Drugs
ketamine
03
Conditions
rattlesnake envenomation
Beyond the preview
Go deeper on NCT05379179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05379179.